Cognitive behavior therapy for autistic adolescents, awareness and care for my autistic traits program: a multicenter randomized controlled trial.

Autism spectrum disorder Cognitive behavioral therapy Family therapy Psychoeducation

Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
07 09 2023
Historique:
received: 01 10 2022
accepted: 02 08 2023
medline: 11 9 2023
pubmed: 8 9 2023
entrez: 7 9 2023
Statut: epublish

Résumé

Autistic people demonstrate focused interests, sensitivity to sensory stimulation, and, compared with the general population, differences in social communication and interaction. We examined whether a combination of the Awareness and Care for My Autistic Traits (ACAT) program and treatment-as-usual is more effective than only treatment-as-usual in increasing the understanding of autistic attributes, reducing treatment stigma, and improving mental health and social adaptation among autistic adolescents and their parents/guardians. Forty-nine adolescents and their parents/guardians were randomly assigned to either a combination of ACAT and treatment-as-usual or only treatment-as-usual. The combined group received six weekly 100-minute ACAT sessions, while the treatment-as-usual group received no additional intervention. The primary outcome was the change in understanding of autistic attributes (Autism Knowledge Quiz-Child), administered from pre- to post-intervention. The secondary outcomes included the change in Autism Knowledge Quiz-Parent, reduced treatment stigma, and improved mental health and social adaptation among autistic adolescents and their parents/guardians. A primary outcome measure scale was scored by assessors who were blind to the group assignment. The combined group (both autistic adolescents and their parents/guardians) showed an increase in Autism Knowledge Quiz scores compared to those in the treatment-as-usual group. Autistic adolescents in the combined group also demonstrated a decrease in treatment-related stigma and an improvement in general mental health compared to those in the treatment-as-usual group, while there were no group differences in the change in social adaptation. For parents/guardians, there were no group differences in the change in treatment-related stigma, general mental health, adaptive skills, or attitudes toward their children. The ACAT program could be an effective treatment modality to increase the understanding of autistic attributes among both autistic adolescents and their parents/guardians. The ACAT program positively affects self-understanding, reduces treatment stigma, and stabilizes behavioral issues for autistic adolescents as a part of mental health measures, but it does not effectively reduce treatment barriers or improve mental health for parents/guardians. Further research should consider whether additional support for parents/guardians could be beneficial. The study was registered in UMIN (UMIN000029851, 06/01/2018).

Sections du résumé

BACKGROUND
Autistic people demonstrate focused interests, sensitivity to sensory stimulation, and, compared with the general population, differences in social communication and interaction. We examined whether a combination of the Awareness and Care for My Autistic Traits (ACAT) program and treatment-as-usual is more effective than only treatment-as-usual in increasing the understanding of autistic attributes, reducing treatment stigma, and improving mental health and social adaptation among autistic adolescents and their parents/guardians.
METHODS
Forty-nine adolescents and their parents/guardians were randomly assigned to either a combination of ACAT and treatment-as-usual or only treatment-as-usual. The combined group received six weekly 100-minute ACAT sessions, while the treatment-as-usual group received no additional intervention. The primary outcome was the change in understanding of autistic attributes (Autism Knowledge Quiz-Child), administered from pre- to post-intervention. The secondary outcomes included the change in Autism Knowledge Quiz-Parent, reduced treatment stigma, and improved mental health and social adaptation among autistic adolescents and their parents/guardians. A primary outcome measure scale was scored by assessors who were blind to the group assignment.
RESULTS
The combined group (both autistic adolescents and their parents/guardians) showed an increase in Autism Knowledge Quiz scores compared to those in the treatment-as-usual group. Autistic adolescents in the combined group also demonstrated a decrease in treatment-related stigma and an improvement in general mental health compared to those in the treatment-as-usual group, while there were no group differences in the change in social adaptation. For parents/guardians, there were no group differences in the change in treatment-related stigma, general mental health, adaptive skills, or attitudes toward their children.
CONCLUSIONS
The ACAT program could be an effective treatment modality to increase the understanding of autistic attributes among both autistic adolescents and their parents/guardians. The ACAT program positively affects self-understanding, reduces treatment stigma, and stabilizes behavioral issues for autistic adolescents as a part of mental health measures, but it does not effectively reduce treatment barriers or improve mental health for parents/guardians. Further research should consider whether additional support for parents/guardians could be beneficial.
TRIAL REGISTRATION
The study was registered in UMIN (UMIN000029851, 06/01/2018).

Identifiants

pubmed: 37679711
doi: 10.1186/s12888-023-05075-2
pii: 10.1186/s12888-023-05075-2
pmc: PMC10485995
doi:

Banques de données

UMIN-CTR
['UMIN000029851']

Types de publication

Randomized Controlled Trial Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

661

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Community Ment Health J. 2001 Feb;37(1):39-52
pubmed: 11300666
J Child Psychol Psychiatry. 1987 Jan;28(1):79-85
pubmed: 3558540
J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1337-45
pubmed: 11699809
Front Psychol. 2021 Oct 28;12:760184
pubmed: 34777164
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
J Autism Dev Disord. 2012 Jun;42(6):1025-36
pubmed: 21858588
J Autism Dev Disord. 2021 Mar;51(3):892-905
pubmed: 32266684
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Autism Res. 2018 Aug;11(8):1138-1147
pubmed: 29734506
Pediatrics. 2013 Nov;132(5):e1341-50
pubmed: 24167175
J Child Psychol Psychiatry. 1987 Jan;28(1):43-60
pubmed: 3558538
Health Qual Life Outcomes. 2003 Nov 13;1:66
pubmed: 14614778
J Autism Dev Disord. 2012 Feb;42(2):230-43
pubmed: 21472359
PLoS One. 2015 Dec 03;10(12):e0143946
pubmed: 26633810
Autism. 2016 May;20(4):442-62
pubmed: 26134030
J Autism Dev Disord. 2000 Jun;30(3):205-23
pubmed: 11055457
J Autism Dev Disord. 2009 Jun;39(6):856-64
pubmed: 19191016
J Autism Dev Disord. 2015 Dec;45(12):3908-18
pubmed: 26395112
J Autism Dev Disord. 2015 Aug;45(8):2553-66
pubmed: 25796194
JAMA Psychiatry. 2020 May 1;77(5):474-483
pubmed: 31755906
Sociol Health Illn. 2009 Nov;31(7):1011-27
pubmed: 19659737
J Child Psychol Psychiatry. 2015 Apr;56(4):468-76
pubmed: 25132516
J Child Psychol Psychiatry. 1981 Jan;22(1):73-88
pubmed: 7451588
Am J Ment Retard. 2006 May;111(3):199-215
pubmed: 16597187
J Ment Defic Res. 1989 Dec;33 ( Pt 6):455-66
pubmed: 2614813
J Affect Disord. 1997 Jan;42(1):59-68
pubmed: 9089059
Autism Res Treat. 2011;2011:405849
pubmed: 22937248
Autism. 2021 Feb;25(2):374-388
pubmed: 32969254
J Couns Psychol. 2018 Jan;65(1):86-97
pubmed: 28541060
Arch Dis Child Educ Pract Ed. 2015 Feb;100(1):20-3
pubmed: 24810156
BMC Psychiatry. 2012 Jun 20;12:36
pubmed: 22546012
Trials. 2020 Sep 29;21(1):814
pubmed: 32993775

Auteurs

Fumiyo Oshima (F)

Research Center for Child Mental Development, Chiba University, 1-8-1 Inohana, Chuouku, 260-8670, Chiba, Japan. f_oshima@chiba-u.jp.
Division of Cognitive Behavioral Science, United Graduate School of Child Development, Chiba University, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University, University of Fukui, Chiba, Japan. f_oshima@chiba-u.jp.

William Mandy (W)

Research Department of Clinical, Educational & Health Psychology, University College London, Gower Street, London, WC1E 6BT, UK.

Mikuko Seto (M)

Research Center for Child Mental Development, Chiba University, 1-8-1 Inohana, Chuouku, 260-8670, Chiba, Japan.

Minako Hongo (M)

Research Center for Child Mental Development, Chiba University, 1-8-1 Inohana, Chuouku, 260-8670, Chiba, Japan.
Division of Cognitive Behavioral Science, United Graduate School of Child Development, Chiba University, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University, University of Fukui, Chiba, Japan.

Aki Tsuchiyagaito (A)

Laureate Instituto for Brain Research, 6655 S Yale Ave, Tulsa, OK, 74136, USA.

Yoshiyuki Hirano (Y)

Research Center for Child Mental Development, Chiba University, 1-8-1 Inohana, Chuouku, 260-8670, Chiba, Japan.
Division of Cognitive Behavioral Science, United Graduate School of Child Development, Chiba University, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University, University of Fukui, Chiba, Japan.

Chihiro Sutoh (C)

Department of Cognitive Behavioral Physiology, Chiba University, 1-8-1 Inohana, Chuouku, 260-8670, Chiba, Japan.

Siqing Guan (S)

Research Center for Child Mental Development, Chiba University, 1-8-1 Inohana, Chuouku, 260-8670, Chiba, Japan.

Yusuke Nitta (Y)

Research Center for Child Mental Development, Chiba University, 1-8-1 Inohana, Chuouku, 260-8670, Chiba, Japan.

Yoshihito Ozawa (Y)

Biostatistics Section, Clinical Research Center, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuouku, 260-8670, Chiba, Japan.

Yohei Kawasaki (Y)

Biostatistics Section, Clinical Research Center, Chiba University Hospital, Chiba University, 1-8-1 Inohana, Chuouku, 260-8670, Chiba, Japan.

Toshiyuki Ohtani (T)

Division of Cognitive Behavioral Science, United Graduate School of Child Development, Chiba University, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University, University of Fukui, Chiba, Japan.
Safety and Health Organization, Chiba University, Chiba, Japan.

Jiro Masuya (J)

Department of Psychiatry, Tokyo Medical University Ibaraki, Medical Center, 3-20-1 3-20-1 Chuo, Ami-machi, Inashiki-gun, Ibaraki, 300-0395, Japan.

Noriko Takahashi (N)

Fukushima University Child Mental Health-Care Center, 1 Kanayagawa, Fukushima, 960-1296, Japan.

Noriyuki Sato (N)

Fukushima University Child Mental Health-Care Center, 1 Kanayagawa, Fukushima, 960-1296, Japan.

Shizuka Nakamura (S)

Fukushima University Child Mental Health-Care Center, 1 Kanayagawa, Fukushima, 960-1296, Japan.

Akiko Nakagawa (A)

Research Center for Child Mental Development, Chiba University, 1-8-1 Inohana, Chuouku, 260-8670, Chiba, Japan.
Division of Cognitive Behavioral Science, United Graduate School of Child Development, Chiba University, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University, University of Fukui, Chiba, Japan.

Eiji Shimizu (E)

Research Center for Child Mental Development, Chiba University, 1-8-1 Inohana, Chuouku, 260-8670, Chiba, Japan.
Division of Cognitive Behavioral Science, United Graduate School of Child Development, Chiba University, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University, University of Fukui, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH